Get to know Biomedical Reproductive Endocrinologist Dr. Sheryene Tejeda, who serves patients in Palm Beach Gardens and Altamonte Springs, Florida & King of Prussia, Pennsylvania.
More on Spindigit:
- Light Up Your Day With Compelling Music Blogs and Exciting Music News
- Enjoy the Steamiest Music News Severed Hot Every Day
- KingZiLLa Is Showing His Skills with the Track ‘AH SUCKERPUSS DELICIOUS LOLLIPOP ADVENTURE’
- Maintain Healthy Lifestyle with Fitness Guru and Author Leo Costa Jr.
- IssueWire Offering Major Media Exposure in Business Press Release Distribution
(Spin Digit Editorial):- New York City, New York Nov 7, 2022 (Issuewire.com) – Dr. Tejeda is a biomedical reproductive endocrinologist serving as the Founder & lead scientist of Medicinal Technologies. She is currently practicing in Palm Beach Gardens and Altamonte Springs, Florida & King of Prussia, Pennsylvania.
Medicinal Technologies is a biomedical company offering natural remedies and integrated innovative medicine for treating endometriosis, infertility, erectile dysfunction, high blood pressure, GERD, circulatory issues, sciatica, arthritis, allergies, some cancers, as well as menopausal symptoms.
Its professional consulting services and comprehensive research data on the latest ways to heal endometriosis and other reproductive and general health issues aim to deliver premium care to you. The goal is to provide collaborative and innovative approaches in biomedicine designed to heal the source of ailments, not just treat their symptoms.
Specializing in women’s and men’s health, particularly the reproductive systems, Dr. Tejeda is known for their contributions to the treatment of endometriosis. With her Ph.D. in Biomedicine, she provides a holistic perspective to ailments that combines a dual approach of western medicine with biomedicine.
Following years of research and clinical trials, this noteworthy doctor has made medical history with a revolutionary breakthrough. Valued at over 5 billion dollars, the protocol is already being pursued purchase by several of the largest pharmaceutical companies worldwide.
Endogen is a biomedical protocol said to have few to no side effects and does not require a prescription. It will first be offered in the United States but ultimately can be purchased regardless of location. This will change the lives of many globally, as according to statistics over 250 million women are diagnosed with endometriosis, and millions more remain undiagnosed.
Among her professional affiliations, Dr. Tejeda is an active member of the Association for Women in Science, the Biomedical Engineering Society, and the National Medical Association.
Reproductive endocrinology and infertility (REI) Biomedicine subspecialty of obstetrics and gynecology that trains physicians in reproductive medicine addressing hormonal functioning as it pertains to reproduction, as well as the issue of infertility. While most REI specialists primarily focus on the treatment of infertility, reproductive endocrinologists are trained to also evaluate and treat hormonal dysfunctions in females and males after the reproductive years.
As a result of her scientific contributions to endometriosis, Dr. Tejeda was featured as a Top Global Doctor in 2022.
Not limited to reproductive endocrinology-related conditions, she continues research on both common and rare diseases and disorders with the goal of offering answers and solutions.
Learn More about Dr. Sheryene Tejeda:
Through her findatopdoc profile, https://www.findatopdoc.com/doctor/84750422-Sheryene-Tejeda-OB-GYN-Obstetrician-Gynecologist or through Medicinal Technologies, https://medicinaltechnologies.com/
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey toward optimal health by providing you with the know-how to make informed decisions for you and your family.
Your Health Contact
Source :Sheryene Tejeda, MD, PhD, MHS, MFS
This article was originally published by IssueWire. Read the original article here.